Non-surgical periodontal treatment of cyclosporin A-induced gingival overgrowth: Immunohistochemical results

Oral Diseases

Volumn 14, Issue 3, 2008, Pages 244-250

  Aimetti, M ^a,b   Romano, F ^a   Marsico, A ^a   Navone, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE   (Italy)

Author keywords

Cyclosporin A gingival overgrowth; Gingival histology; Immunohistochemistry; Non surgical periodontal treatment; Scaling

Indexed keywords

BIOTIN; CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CYCLOSPORIN A; EOSIN; HEMATOXYLIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PEROXIDASE; STREPTAVIDIN; VIMENTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; GINGIVA OVERGROWTH; GINGIVAL BIOPSY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIVER GRAFT; MALE; MOUTH HYGIENE; PREVENTIVE DENTISTRY; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD34; CASE-CONTROL STUDIES; CYCLOSPORINE; DENTAL PLAQUE; DENTAL SCALING; FEMALE; GINGIVA; GINGIVAL OVERGROWTH; GINGIVITIS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KI-67 ANTIGEN; LIVER TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; ORAL HYGIENE; VIMENTIN;

EID: 40749125696     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01364.x     Document Type: Article

References (32)

1. Aimetti M, Romano F, Debernardi C (2005). Effectiveness of periodontal therapy on the severity of cyclosporin A-induced gingival overgrowth. Clinical results. J Clin Periodontol 32: 273 279.
2. Akiyama S, Amano A, Kato T, Takaday Y, Kimura KR, Morisaki I (2006). Relationship of periodontal bacteria and Porphyromonas gingivalis fimA variations with phenytoin-induced gingival overgrowth. Oral Dis 12: 51 56.
3. Ashrafi SH, Slaski K, Neiman ES, Cunningham MP (1996). Scanning electron microscopy of cyclosporine-induced gingival overgrowth. Scanning Microsc 10: 219 224.
4. Barber MT, Savage NW, Seymour GJ (1992). The effect of cyclosporin and lipopolysaccharide on fibroblasts: implications for cyclosporin-induced gingival overgrowth. J Periodontol 63: 397 404.
5. Boltchi FE, Rees TD, Iacopino AM (1999). Cyclosporin A-induced gingival overgrowth: a comprehensive review. Quintessence Int 30: 775 783.
6. Ellis JS, Seymour RA, Thomason JM, Butler TM, Idle J (1995). Periodontal factors affecting crevicular fluid sequestration of nifedipine in drug-induced gingival overgrowth. J Periodontal Res 30: 272 276.
7. James JA, Irwin CR, Linden GJ (1995). The effects of culture environment on the response of human gingival fibroblasts to cyclosporin A. J Periodontol 66: 339 344.
8. Kantarci A, Cebeci I, Tuncer Ö, Çarin M, Firatli E (1999). Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. J Periodontol 70: 587 593.
9. Kovacs EJ (1991). Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 39: 631 638.
10. Löe H, Silness J (1963). Periodontal disease in pregnancy. (I). Prevalence and severity. Acta Odontol Scand 21: 533 551.
11. Mariani G, Calastrini C, Carinci F, Bergamini L, Calastrini F, Stabellini G (1996). Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth. J Periodontol 67: 21 27.
12. Montebugnoli L, Servidio D, Bernardi F (2000). The rôle of time in reducing gingival overgrowth in heart-transplanted patients following cyclosporin therapy. J Clin Periodontol 27: 611 614.
13. Nurmenniemi PK, Pernu HE, Knuuttila MLE (1999). Density of CD1a-labeled Langherans' cells in normal human gingiva and in nifedipine- and immunosuppressive medication- induced gingival overgrowth. J Periodontol 70: 25 756.
14. Nurmenniemi PK, Pernu HE, Knuuttila MLE (2001). Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 72: 167 173.
15. Nurmenniemi PK, Pernu HE, Laukkanen P, Knuuttila MLE (2002). Macrophage subpopulations in gingival overgrowth induced by nifedipine and immunosuppressive medication. J Periodontol 73: 1323 1330.
16. O'Valle F, Mesa FL, Gomez-Morales M et al. (1994). Immunohistochemical study of 30 cases of cyclosporin A-induced gingival overgrowth. J Periodontol 65: 724 730.
17. Pernu HE, Knuuttila MLE (2001). Macrophages and lymphocyte subpopulations in nifedipine- and cyclosporin A-associated human gingival overgrowth. J Periodontol 72: 160 166.
18. Romito GA, Pustiglioni FE, Saraiva L, Pustiglioni AN, Fraga Moreira Lotufo R, Groppo Stolf NA (2004). Relationship of subgingival and salivary microbiota to gingival overgrowth in heart transplant patients following cyclosporin A therapy. J Periodontol 75: 918 924.
19. Saito K, Mori S, Tanda N, Sakamoto S (1999). Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol 70: 581 586.
20. Seymour RA, Jacobs DJ (1992). Cyclosporin and the gingival tissues. J Clin Periodontol 19: 1 11.
21. Seymour RA, Smith DG (1991). The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 18: 107 110.
22. Seymour RA, Smith DG, Turnbull DN (1985). The effect of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 12: 413 419.
23. Seymour RA, Ellis JS, Thomanson JM (2000). Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 27: 217 223.
24. Silness J, Löe H (1964). Periodontal disease in pregnancy. (II). Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22: 121 135.
25. Spolidorio LC, Merzel J, Villalba H, Vargas PA, Coletta RD, Almeida OP (2001). Morphometric evaluation of gingival overgrowth and regression caused by cyclosporin in rats. J Periodontal Res 36: 384 389.
26. Stabellini G, Calastrini C, Mariani G et al. (2004). Extracellular glycosaminoglycan changes in healthy and overgrown gingiva fibroblasts after cyclosporin A and cytokine treatments. J Oral Pathol Med 33: 346 353.
27. Sugano N, Ito K, Murai S (1998). Cyclosporin A inhibits collagenase gene expression via AP-1 and JNK suppression in human gingival fibroblasts. J Periodontal Res 33: 448 452.
28. Thomason JM, Seymour RA, Ellis JS (2005). Risk factors for gingival overgrowth in patients medicated with cyclosporin in the absence of calcium channel blockers. J Clin Periodontol 32: 273 279.
29. Uzel MI, Kantarci A, Hong HH et al. (2001). Connective-tissue growth factor in drug-induced gingival overgrowth. J Periodontol 72: 921 931.
30. Vardar S, Baylas H, Zihnioǧlu F, Emingil G, Buduneli N, Atilla G (2004). Total proteoglycan and chondroitin-4-sulfate levels in gingiva of patients with various types of periodontitis. J Periodontol 75: 393 398.
31. Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM (1994). Cyclosporin A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 65: 895 903.
32. Wondimu B, Reinholt FP, Modèer T (1995). Stereologic study of cyclosporin A-induced gingival overgrowth in renal transplant patients. Eur J Oral Sci 103: 199 206.